The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Scoliosis and Kyphosis Prevalence in Turner Syndrome: A Retrospective Review at a Pediatric Tertiary Care Medical Center
Abstract
BACKGROUND: The prevalence of major coronal and sagittal spinal curves (scoliosis and kyphosis) in Turner syndrome (TS) is not well established due to limited reporting. The relationship between growth hormone (GH) therapy and its effect on TS spinal curve incidence is also not well established. METHODS: A retrospective chart review of 306 TS patients from 2007 to 2021 evaluated major coronal and sagittal spinal curves, progression of the curve, and treatment with GH. Statistical significance (defined as P <0.05) between curvature rates and curve progression was compared between GH-treated patients and non-GH-treated patients using a χ 2 or Fisher exact test when appropriate. RESULTS: Thirty-seven of 306 (12%) TS patients had a radiographically relevant spinal deformity. Twenty-seven of 37 (73%) had mild; 4 of 37 (11%) had moderate, and 6 of 37 (16%) had severe curves. Of those with severe, 4 underwent spinal fusion, 1 was treated with bracing, and 1 was braced before a cardiovascular-related death. Regarding GH use among TS patients, 190 of 306 (62%) used GH versus 116 of 306 (38%) who did not. Of those with a spinal curve, 24 of 37 (65%) used GH compared with 13 of 37 (35%) who did not. On univariate analysis, GH therapy was not a risk factor for the diagnosis of a major spinal curve, a more severe degree of the curve at the time of diagnosis, or spinal curve progression ( P >0.05 for all). CONCLUSIONS: This is the largest single institution retrospective review of a TS cohort known to the authors assessing spinal curve prevalence and relation to GH treatment and demonstrates a TS spinal curve rate of 12% (37/306). Four of six (11%) TS patients with a severe curve underwent corrective spine fusion. There was no relationship between the use of GH and the presence of a spinal curve or curve progression. Further study is warranted to determine risk factors for curve progression. LEVEL OF EVIDENCE: Level III. CLINICAL RELEVANCE: This retrospective case series serves to review and address the prevalence of spinal deformity in TS patients and whether GH impacts worsening deformity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Two studies demonstrated no increased risk of developing or worsening scoliosis with GH therapy in TS.
“but two studies demonstrated no increased risk of developing scoliosis or worsening existing scoliosis with GH therapy160,215 in TS.”
From Clinical practice guidelines for the care of girls and women with Turner syndrome. (2024) · cites this paper as [215]
Citations
Cites
Gravholt, C. H., Andersen, N. H., Conway, G. S., Dekkers, O. M., Geffner, M. E., Klein, K. O., Lin, A. E., Mauras, N., Quigley, C. A., Rubin, K., et al. (2017) · European Journal of Endocrinology · doi:10.1530/eje-17-0430 · Cited by 1,101
Adolescent idiopathic scoliosis: review and current concepts.
Reamy, B. V., & Slakey, J. B. (2001) · PubMed · Cited by 411
Adolescent idiopathic scoliosis
Altaf, F., Gibson, A., Dannawi, Z., et al. (2013) · BMJ · doi:10.1136/bmj.f2508 · Cited by 344
Aetiology of idiopathic scoliosis: current concepts
Burwell, R. G. (2003) · Developmental Neurorehabilitation · doi:10.1080/13638490310001642757 · Cited by 193
Long-term safety of recombinant human growth hormone in Turner syndrome
Bolar, K., Hoffman, A. R., Maneatis, T., & Lippe, B. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1723 · Cited by 116
The etiology of adolescent idiopathic scoliosis.
Ahn, U. M., Ahn, N. U., Nallamshetty, L., et al. (2002) · PubMed · Cited by 94
Increased prevalence of scoliosis in Turner syndrome
Kim, J. Y., Rosenfeld, S. R., & Keyak, J. H. (2001) · Journal of Pediatric Orthopaedics · doi:10.1097/01241398-200111000-00012 · Cited by 49
Scoliosis in Patients Treated with Growth Hormone
Wang, E. D., Drummond, D. S., Dormans, J. P., Moshang, T., Davidson, R. S., & Gruccio, D. (1997) · Journal of Pediatric Orthopaedics · doi:10.1097/01241398-199711000-00003 · Cited by 49
Kyphosis in a Turner Syndrome Population
Elder, D. A., Roper, M. G., Henderson, R. C., & Davenport, M. L. (2002) · PEDIATRICS · doi:10.1542/peds.109.6.e93 · Cited by 33
Ricotti, S., Petrucci, L., Carenzio, G., Klersy, C., Calcaterra, V., Larizza, D., & Toffola, E. D. (2011) · PubMed · Cited by 29
Childhood growth hormone treatment in women with Turner syndrome - benefits and adverse effects
Irzyniec, T. J., Jeż, W., Lepska, K., Maciejewska-Paszek, I., & Frelich, J. (2019) · Scientific Reports · doi:10.1038/s41598-019-52332-0 · Cited by 25
Orthopaedic Manifestations in Turner Syndrome
Acosta, A. M., Steinman, S. E., & White, K. K. (2019) · Journal of the American Academy of Orthopaedic Surgeons · doi:10.5435/jaaos-d-17-00796 · Cited by 22
Day, G., Szvetko, A. L., Griffiths, L. R., et al. (2009) · PubMed · doi:10.1002/jor.20801 · Cited by 4
THE INCIDENCE OF IDIOPATHIC SCOLIOSIS IN TURNER SYNDROME – GROWTH HORMONE TREATED AND NON-TREATED.
Day, G. A., McPhee, I. B., & Batch, J. (2004) · Orthopaedic Proceedings · Cited by 3
Flagged first, then by citations
Cited by
Sorted by citations
Clinical practice guidelines for the care of girls and women with Turner syndrome.
Gravholt, C. H., Andersen, N. H., Christin-Maitre, S., Davis, S. M., Duijnhouwer, A., Gawlik, A., Maciel-Guerra, A. T., Gutmark-Little, I., Fleischer, K., Hong, D., et al. (2024) · European Journal of Endocrinology · doi:10.1093/ejendo/lvae050 · Cited by 224
Metadata
- Authors
- Marx, J. S., Pagadala, M., Carney, J., Gerlach, E., Swiatek, P., Zabinsky, J. A., Sarwark, J., Brickman, W. J., & Habiby, R. L.
- Affiliations
- Lurie Children's Hospital (US)
- Northwestern University (US)
- Division of Orthopaedics
- Corresponding author
- Marx, Jeremy S.
- Pagadala, Manasa
- Carney, John
- Gerlach, Erik
- Swiatek, Peter
- Sarwark, John
- Venue
- Journal of Pediatric Orthopaedics
- Published
- 2023-02-15
- Volume
- 43
- Issue
- 5
- Pages
- 299-302
- ISSN
- 0271-6798 (ISSN-L)
- OpenAlex
- W4320892181
- Cited by
- 7
- References
- 14
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 3
- FWCI
- 1.87
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Pediatric Orthopaedics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Scoliosis diagnosis and treatment
- Health Sciences › Medicine › Surgery › Pectus Deformity Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities
- Keywords
- Turner syndrome, scoliosis, kyphosis, growth hormone therapy, spinal fusion, bracing
- MeSH terms
- Child, Humans, Kyphosis, Retrospective Studies, Scoliosis, Spinal Fusion, Turner Syndrome, Prevalence, Treatment Outcome, Tertiary Health Care
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review